When should treatment for bacterial conjunctivitis in neonates be initiated?

In neonates, bacterial conjunctivitis can lead to serious complications if left untreated, including potential vision loss or systemic infection. Initiating treatment immediately upon clinical suspicion is essential for several reasons.

Firstly, the neonate's immune system is still developing, making them more vulnerable to infections. Early intervention can help prevent the infection from worsening and reduce the risk of complications.

Secondly, neonates may exhibit symptoms of bacterial conjunctivitis, such as redness, swelling, and discharge, without the luxury of waiting for laboratory confirmation, which can delay necessary treatment and increase the risk of adverse outcomes.

Given these factors, it is critical to act quickly when there is a clinical suspicion of bacterial conjunctivitis in neonates. This proactive approach aligns with the best practices for managing infections in this vulnerable population.